Synopsis
0
JDMF
0
EU WC
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
ABOUT THIS PAGE
84
PharmaCompass offers a list of Nomegestrol Acetate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Nomegestrol Acetate manufacturer or Nomegestrol Acetate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Nomegestrol Acetate manufacturer or Nomegestrol Acetate supplier.
PharmaCompass also assists you with knowing the Nomegestrol Acetate API Price utilized in the formulation of products. Nomegestrol Acetate API Price is not always fixed or binding as the Nomegestrol Acetate Price is obtained through a variety of data sources. The Nomegestrol Acetate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Monaco manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Monaco, including repackagers and relabelers. The FDA regulates Monaco manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Monaco API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Monaco manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Monaco supplier is an individual or a company that provides Monaco active pharmaceutical ingredient (API) or Monaco finished formulations upon request. The Monaco suppliers may include Monaco API manufacturers, exporters, distributors and traders.
click here to find a list of Monaco suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Monaco DMF (Drug Master File) is a document detailing the whole manufacturing process of Monaco active pharmaceutical ingredient (API) in detail. Different forms of Monaco DMFs exist exist since differing nations have different regulations, such as Monaco USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Monaco DMF submitted to regulatory agencies in the US is known as a USDMF. Monaco USDMF includes data on Monaco's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Monaco USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Monaco suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Monaco Drug Master File in Korea (Monaco KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Monaco. The MFDS reviews the Monaco KDMF as part of the drug registration process and uses the information provided in the Monaco KDMF to evaluate the safety and efficacy of the drug.
After submitting a Monaco KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Monaco API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Monaco suppliers with KDMF on PharmaCompass.
A Monaco CEP of the European Pharmacopoeia monograph is often referred to as a Monaco Certificate of Suitability (COS). The purpose of a Monaco CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Monaco EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Monaco to their clients by showing that a Monaco CEP has been issued for it. The manufacturer submits a Monaco CEP (COS) as part of the market authorization procedure, and it takes on the role of a Monaco CEP holder for the record. Additionally, the data presented in the Monaco CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Monaco DMF.
A Monaco CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Monaco CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Monaco suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Monaco as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Monaco API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Monaco as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Monaco and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Monaco NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Monaco suppliers with NDC on PharmaCompass.
Monaco Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Monaco GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Monaco GMP manufacturer or Monaco GMP API supplier for your needs.
A Monaco CoA (Certificate of Analysis) is a formal document that attests to Monaco's compliance with Monaco specifications and serves as a tool for batch-level quality control.
Monaco CoA mostly includes findings from lab analyses of a specific batch. For each Monaco CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Monaco may be tested according to a variety of international standards, such as European Pharmacopoeia (Monaco EP), Monaco JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Monaco USP).
